Coumarin-Rasagiline Hybrids as Potent and Selective hMAO-B Inhibitors, Antioxidants, and Neuroprotective Agents

dc.creatorMatos M.J.
dc.creatorHerrera Ibatá D.M.
dc.creatorUriarte E.
dc.creatorViña D.
dc.date.accessioned2020-09-02T22:23:01Z
dc.date.accessioned2022-11-08T20:21:37Z
dc.date.available2020-09-02T22:23:01Z
dc.date.available2022-11-08T20:21:37Z
dc.date.created2020-09-02T22:23:01Z
dc.date.issued2020
dc.identifier15, 6, 532-538
dc.identifier18607179
dc.identifierhttps://hdl.handle.net/20.500.12728/5337
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5144099
dc.languageen
dc.publisherJohn Wiley and Sons Ltd
dc.subjectAntioxidants
dc.subjectCoumarin-rasagiline hybrids
dc.subjecthMAO-B inhibitors
dc.subjectNeuroprotectors
dc.subjectParkinson's disease
dc.subject4 (but 2 yn 1 ylamino)coumarin
dc.subjectamine oxidase (flavin containing) isoenzyme B
dc.subjectantioxidant
dc.subjectcoumarin
dc.subjectmonoamine oxidase inhibitor
dc.subjectneuroprotective agent
dc.subjectrasagiline
dc.subjectunclassified drug
dc.subjectanimal experiment
dc.subjectantioxidant activity
dc.subjectArticle
dc.subjectDPPH radical scavenging assay
dc.subjectembryo
dc.subjectenzyme inhibition
dc.subjectneuroprotection
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectrat
dc.titleCoumarin-Rasagiline Hybrids as Potent and Selective hMAO-B Inhibitors, Antioxidants, and Neuroprotective Agents
dc.typeArticle


Este ítem pertenece a la siguiente institución